BRAFV600E, hypothyroidism, and human relaxin in thyroid carcinogenesis

No abstract is available for this paper.

• Publication year

  2020

• Venue

  Journal of Cancer Research and Clinical Oncology

• Publication date

  2020-09-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00432-020-03401-9PMID 32995956PMCID PMC7855918
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• International Classification of Diseases for Oncology

  2020cited by this paper
• Hypothyroidism and its Association with Sleep Apnea Among Adults in The United States: NHANES 2007-2008.

  2019cited by this paper
• Role of Emerging Environmental Risk Factors in Thyroid Cancer: A Brief Review

  2019cited by this paper
• BRAF-Oncogene-Induced Senescence and the Role of Thyroid-Stimulating Hormone Signaling in the Progression of Papillary Thyroid Carcinoma

  2018cited by this paper
• Global epidemiology of hyperthyroidism and hypothyroidism

  2018cited by this paper
• Thyroid Disrupting Chemicals

  2017cited by this paper
• Interaction between angiotensin II and relaxin 2 in the progress of growth and spread of prostate cancer cells.

  2016cited by this paper
• The changing characteristics and molecular profiles of papillary thyroid carcinoma over time: a systematic review

  2016cited by this paper
• Relaxin-2 Expression in Oral Squamous Cell Carcinoma

  2016cited by this paper
• Annual Report to the Nation on the Status of Cancer, 1975‐2012, featuring the increasing incidence of liver cancer

  2016cited by this paper
• Associations between BRAFV600E and prognostic factors and poor outcomes in papillary thyroid carcinoma: a meta-analysis

  2016cited by this paper
• TSH overcomes BrafV600E-induced senescence to promote tumor progression via downregulation of p53 expression in papillary thyroid cancer

  2016cited by this paper
• TCGA finds thyroid cancer drivers, subtypes.

  2015cited by this paper
• Inhibition of type 1 17β-hydroxysteroid dehydrogenase impairs the synthesis of 17β-estradiol in endometriosis lesions.

  2014cited by this paper
• An update on molecular biology of thyroid cancers.

  2014cited by this paper
• The increase in thyroid cancer incidence during the last four decades is accompanied by a high frequency of BRAF mutations and a sharp increase in RAS mutations.

  2014cited by this paper
• Annual Report to the Nation on the status of cancer, 1975‐2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer

  2014cited by this paper
• Mechanisms in endocrinology: the crosstalk between thyroid gland and adipose tissue: signal integration in health and disease.

  2014cited by this paper
• Integrated genomic characterization of papillary thyroid carcinoma.

  2014cited by this paper
• Hashimoto's thyroiditis and papillary thyroid cancer: are they immunologically linked?

  2014cited by this paper
• Cancer incidence trends among Asian American populations in the United States, 1990-2008.

  2013cited by this paper
• Significance of relaxin-2 expression in hepatocellular carcinoma: relation with clinicopathological parameters.

  2013cited by this paper
• Immunohistochemical detection of mutated BRAF V600E supports the clonal origin of BRAF-induced thyroid cancers along the spectrum of disease progression.

  2013cited by this paper
• Human relaxin-2: historical perspectives and role in cancer biology

  2012cited by this paper
• Angiogenesis , Metastasis , and the Cellular Microenvironment Relaxin Enhances the Collagenolytic Activity and In Vitro Invasiveness by Upregulating Matrix Metalloproteinases in Human Thyroid Carcinoma Cells

  2011cited by this paper
• Higher rate of BRAF mutation in papillary thyroid cancer over time

  2011cited by this paper
• Molecular genetics and diagnosis of thyroid cancer

  2011cited by this paper
• Thyrotrophin receptor signaling dependence of Braf-induced thyroid tumor initiation in mice

  2011cited by this paper
• Thyroid and obesity: an intriguing relationship.

  2010cited by this paper
• Are endogenously lower serum thyroid hormones new predictors for thyroid malignancy in addition to higher serum thyrotropin?

  2010cited by this paper
• Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role.

  2009cited by this paper
• Endogenous Thyrotropin and Triiodothyronine Concentrations in Individuals with Thyroid Cancer

  2008cited by this paper
• Radiation carcinogenesis: lessons from Chernobyl

  2008cited by this paper
• Relaxin-like ligand-receptor systems are autocrine/paracrine effectors in tumor cells and modulate cancer progression and tissue invasiveness.

  2007cited by this paper
• Relaxin Promotes Prostate Cancer Progression

  2007cited by this paper
• The role of relaxin in endometrial cancer

  2006cited by this paper
• Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration.

  2006cited by this paper
• Relaxin Stimulates Multiple Signaling Pathways: Activation of cAMP, PI3K, and PKCζ in THP‐1 Cells

  2005cited by this paper
• Hypothyroidism in the Elderly: Pathophysiology, Diagnosis and Treatment

  2005cited by this paper
• Elevated Concentrations of Serum Relaxin are Associated with Metastatic Disease in Breast Cancer Patients

  2004cited by this paper
• A pooled analysis of case–control studies of thyroid cancer. VII. Cruciferous and other vegetables (International)

  2002cited by this paper
• Relaxin enhances in-vitro invasiveness of breast cancer cell lines by up-regulation of matrix metalloproteases.

  2002cited by this paper
• Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III).

  2002cited by this paper
• Cohort study of thyroid cancer in a San Francisco Bay area population

  2001cited by this paper
• Descriptive epidemiology of thyroid cancer in Los Angeles County, 1972–1995

  2000cited by this paper
• A pooled analysis of case–control studies of thyroid cancer. IV. Benign thyroid diseases

  1999cited by this paper
• Cancer incidence among filipinos in los angeles county, 1972–1991

  1995cited by this paper
• Thyroid cancer incidence in Asian migrants to the United States and their descendants

  1995cited by this paper
• Thyroid tumors.

  1990cited by this paper
• Descriptive epidemiology of thyroid cancer in Hawaii

  1988cited by this paper
• Effect of relaxin on thyroid function in the rat.

  1963cited by this paper
• The effect of relaxin on thyroid weights in laboratory animals.

  1960cited by this paper
• Tumorigenesis and Neoplastic Progression Relaxin Enhances the Oncogenic Potential of Human Thyroid Carcinoma Cells

  year unknowncited by this paper

• Role of relaxin signaling in Cancer: A review.

  2024cites this paper
• Recent development on nanomaterial‐based biosensors for identifying thyroid tumor biomarkers

  2024cites this paper
• A review of complex hormone regulation in thyroid cancer: novel insights beyond the hypothalamus–pituitary–thyroid axis

  2024cites this paper
• Multi-trait analysis characterizes the genetics of thyroid function and identifies causal associations with clinical implications

  2024cites this paper
• Interaction of BANCR in the relationship between Hashimoto’s thyroiditis and papillary thyroid carcinoma expression patterns and possible molecular mechanisms

  2024cites this paper
• Relaxin-2 is a novel biomarker for differentiated thyroid carcinoma in humans.

  2024cites this paper
• The dual and multifaceted role of relaxin-2 in cancer

  2023cites this paper
• The Causal Effects of Primary Biliary Cholangitis on Thyroid Dysfunction: A Two-Sample Mendelian Randomization Study

  2021cites this paper